Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
To increase efficiencies and accelerate the drug discovery and development process, Creative Biolabs offers a broad range of early development services, especially for TCR engineered T cell design, construct, validation, and function assessment. Particularly, the generation and optimization of TCR is the key step of TCR development, which can be specially tailored to your project. Creative Biolabs can offer you several creative approaches to generate TCRs that are specific for the antigens that are expressed by a wider variety of tumor cell types to meet your special needs and also has optimized strategies to increase TCR affinity.
TCR Generation & Optimization Platform
| 1. TCR Generation |
|
2. TCR Optimization |
|
3. TCR Characterization |
| TCR Generated from patient's TIL TCR Generated from Phage Display TCR Generated from In Vivo System | TCR Affinity Optimization TCR Affinity Maturation TCR Specificity Enhancement |
|
Based on the outstanding expertise and rich experience, Creative Biolabs has specially developed a system approach of TCR generation for TCR development. Particularly, we offer our clients a special pipeline of antigen-specific TCR-T cell generation in terms of the method of direct targeting of human tumors using autologous TILs to meet your needs. We also provide TCRs generated from phage display. The phage surface display is an effective technology optimized by our expert team, which will be signally promoting the ability of recognition to tumor antigen. In addition, TCR transgenic model is developed by Creative Biolabs to determine the magnitude of T cell tolerance to tumor-associated antigen. T cells are incubated with tumor cells from the patient and TCR genes are cloned from T cells that react to the tumor cells so that high-affinity TCRs for the target antigen are generated.
Altering the specificity of T cell receptor (TCR) is one of the most popular strategies for genetically modifying T cells to enhance the tumor-killing activity of T cells. Creative Biolabs offers you three classics strategies to solve the problems, including TCR-C Murinization, Incorporation of Additional Cysteine Residue, and Increasing Avidity.
To obtain higher TCR affinity mature level for many efficient results in further research, we have successfully operated a platform for affinity maturation service, which can especially be used for TCR. Some vital methods/steps are as follows:
For further details, please don't hesitate to contact us.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
